Endogenous glucocorticoids decrease skeletal angiogenesis, vascularity, hydration, and strength in aged mice

Robert S. Weinstein, Chao Wan, Qinglan Liu, Ying Wang, Maria Almeida, Charles A. O'Brien, Jeff Thostenson, Paula K. Roberson, Adele L. Boskey, Thomas Clemens, Stavros C. Manolagas

Research output: Contribution to journalArticle

Abstract

Aging or glucocorticoid excess decrease bone strength more than bone mass in humans and mice, but an explanation for this mismatch remains elusive. We report that aging in C57BL/6 mice was associated with an increase in adrenal production of glucocorticoids as well as bone expression of 11β-hydroxysteroid dehydrogenase (11β-HSD) type 1, the enzyme that activates glucocorticoids. Aging also decreased the volume of the bone vasculature and solute transport from the peripheral circulation to the lacunar-canalicular system. The same changes were reproduced by pharmacologic hyperglucocorticoidism. Furthermore, mice in which osteoblasts and osteocytes were shielded from glucocorticoids via cell-specific transgenic expression of 11β-HSD type 2, the enzyme that inactivates glucocorticoids, were protected from the adverse effects of aging on osteoblast and osteocyte apoptosis, bone formation rate and microarchitecture, crystallinity, vasculature volume, interstitial fluid, and strength. In addition, glucocorticoids suppressed angiogenesis in fetal metatarsals and hypoxia inducible factor-1α transcription and vascular endothelial growth factor production in osteoblasts and osteocytes. These results, together with the evidence that dehydration of bone decreases strength, reveal that endogenous glucocorticoids increase skeletal fragility in old age as a result of cell autonomous effects on osteoblasts and osteocytes leading to interconnected decrements in bone angiogenesis, vasculature volume, and osteocyte-lacunar-canalicular fluid.

Original languageEnglish (US)
Pages (from-to)147-161
Number of pages15
JournalAging Cell
Volume9
Issue number2
DOIs
StatePublished - Apr 2010
Externally publishedYes

Fingerprint

Glucocorticoids
Osteocytes
Osteoblasts
Bone and Bones
11-beta-Hydroxysteroid Dehydrogenases
Fetal Hypoxia
Hypoxia-Inducible Factor 1
Metatarsal Bones
Extracellular Fluid
Enzymes
Inbred C57BL Mouse
Dehydration
Osteogenesis
Vascular Endothelial Growth Factor A
Apoptosis

Keywords

  • 11β-hydroxysteroid dehydrogenase
  • Aging
  • Angiogenesis
  • Apoptosis
  • Bone histomorphometry
  • Glucocorticoids
  • Hydraulic support
  • Osteoporosis

ASJC Scopus subject areas

  • Cell Biology
  • Aging

Cite this

Weinstein, R. S., Wan, C., Liu, Q., Wang, Y., Almeida, M., O'Brien, C. A., ... Manolagas, S. C. (2010). Endogenous glucocorticoids decrease skeletal angiogenesis, vascularity, hydration, and strength in aged mice. Aging Cell, 9(2), 147-161. https://doi.org/10.1111/j.1474-9726.2009.00545.x

Endogenous glucocorticoids decrease skeletal angiogenesis, vascularity, hydration, and strength in aged mice. / Weinstein, Robert S.; Wan, Chao; Liu, Qinglan; Wang, Ying; Almeida, Maria; O'Brien, Charles A.; Thostenson, Jeff; Roberson, Paula K.; Boskey, Adele L.; Clemens, Thomas; Manolagas, Stavros C.

In: Aging Cell, Vol. 9, No. 2, 04.2010, p. 147-161.

Research output: Contribution to journalArticle

Weinstein, RS, Wan, C, Liu, Q, Wang, Y, Almeida, M, O'Brien, CA, Thostenson, J, Roberson, PK, Boskey, AL, Clemens, T & Manolagas, SC 2010, 'Endogenous glucocorticoids decrease skeletal angiogenesis, vascularity, hydration, and strength in aged mice', Aging Cell, vol. 9, no. 2, pp. 147-161. https://doi.org/10.1111/j.1474-9726.2009.00545.x
Weinstein, Robert S. ; Wan, Chao ; Liu, Qinglan ; Wang, Ying ; Almeida, Maria ; O'Brien, Charles A. ; Thostenson, Jeff ; Roberson, Paula K. ; Boskey, Adele L. ; Clemens, Thomas ; Manolagas, Stavros C. / Endogenous glucocorticoids decrease skeletal angiogenesis, vascularity, hydration, and strength in aged mice. In: Aging Cell. 2010 ; Vol. 9, No. 2. pp. 147-161.
@article{8608d6ef81ae4431879c9214f1faf3e0,
title = "Endogenous glucocorticoids decrease skeletal angiogenesis, vascularity, hydration, and strength in aged mice",
abstract = "Aging or glucocorticoid excess decrease bone strength more than bone mass in humans and mice, but an explanation for this mismatch remains elusive. We report that aging in C57BL/6 mice was associated with an increase in adrenal production of glucocorticoids as well as bone expression of 11β-hydroxysteroid dehydrogenase (11β-HSD) type 1, the enzyme that activates glucocorticoids. Aging also decreased the volume of the bone vasculature and solute transport from the peripheral circulation to the lacunar-canalicular system. The same changes were reproduced by pharmacologic hyperglucocorticoidism. Furthermore, mice in which osteoblasts and osteocytes were shielded from glucocorticoids via cell-specific transgenic expression of 11β-HSD type 2, the enzyme that inactivates glucocorticoids, were protected from the adverse effects of aging on osteoblast and osteocyte apoptosis, bone formation rate and microarchitecture, crystallinity, vasculature volume, interstitial fluid, and strength. In addition, glucocorticoids suppressed angiogenesis in fetal metatarsals and hypoxia inducible factor-1α transcription and vascular endothelial growth factor production in osteoblasts and osteocytes. These results, together with the evidence that dehydration of bone decreases strength, reveal that endogenous glucocorticoids increase skeletal fragility in old age as a result of cell autonomous effects on osteoblasts and osteocytes leading to interconnected decrements in bone angiogenesis, vasculature volume, and osteocyte-lacunar-canalicular fluid.",
keywords = "11β-hydroxysteroid dehydrogenase, Aging, Angiogenesis, Apoptosis, Bone histomorphometry, Glucocorticoids, Hydraulic support, Osteoporosis",
author = "Weinstein, {Robert S.} and Chao Wan and Qinglan Liu and Ying Wang and Maria Almeida and O'Brien, {Charles A.} and Jeff Thostenson and Roberson, {Paula K.} and Boskey, {Adele L.} and Thomas Clemens and Manolagas, {Stavros C.}",
year = "2010",
month = "4",
doi = "10.1111/j.1474-9726.2009.00545.x",
language = "English (US)",
volume = "9",
pages = "147--161",
journal = "Aging Cell",
issn = "1474-9718",
publisher = "Wiley-Blackwell",
number = "2",

}

TY - JOUR

T1 - Endogenous glucocorticoids decrease skeletal angiogenesis, vascularity, hydration, and strength in aged mice

AU - Weinstein, Robert S.

AU - Wan, Chao

AU - Liu, Qinglan

AU - Wang, Ying

AU - Almeida, Maria

AU - O'Brien, Charles A.

AU - Thostenson, Jeff

AU - Roberson, Paula K.

AU - Boskey, Adele L.

AU - Clemens, Thomas

AU - Manolagas, Stavros C.

PY - 2010/4

Y1 - 2010/4

N2 - Aging or glucocorticoid excess decrease bone strength more than bone mass in humans and mice, but an explanation for this mismatch remains elusive. We report that aging in C57BL/6 mice was associated with an increase in adrenal production of glucocorticoids as well as bone expression of 11β-hydroxysteroid dehydrogenase (11β-HSD) type 1, the enzyme that activates glucocorticoids. Aging also decreased the volume of the bone vasculature and solute transport from the peripheral circulation to the lacunar-canalicular system. The same changes were reproduced by pharmacologic hyperglucocorticoidism. Furthermore, mice in which osteoblasts and osteocytes were shielded from glucocorticoids via cell-specific transgenic expression of 11β-HSD type 2, the enzyme that inactivates glucocorticoids, were protected from the adverse effects of aging on osteoblast and osteocyte apoptosis, bone formation rate and microarchitecture, crystallinity, vasculature volume, interstitial fluid, and strength. In addition, glucocorticoids suppressed angiogenesis in fetal metatarsals and hypoxia inducible factor-1α transcription and vascular endothelial growth factor production in osteoblasts and osteocytes. These results, together with the evidence that dehydration of bone decreases strength, reveal that endogenous glucocorticoids increase skeletal fragility in old age as a result of cell autonomous effects on osteoblasts and osteocytes leading to interconnected decrements in bone angiogenesis, vasculature volume, and osteocyte-lacunar-canalicular fluid.

AB - Aging or glucocorticoid excess decrease bone strength more than bone mass in humans and mice, but an explanation for this mismatch remains elusive. We report that aging in C57BL/6 mice was associated with an increase in adrenal production of glucocorticoids as well as bone expression of 11β-hydroxysteroid dehydrogenase (11β-HSD) type 1, the enzyme that activates glucocorticoids. Aging also decreased the volume of the bone vasculature and solute transport from the peripheral circulation to the lacunar-canalicular system. The same changes were reproduced by pharmacologic hyperglucocorticoidism. Furthermore, mice in which osteoblasts and osteocytes were shielded from glucocorticoids via cell-specific transgenic expression of 11β-HSD type 2, the enzyme that inactivates glucocorticoids, were protected from the adverse effects of aging on osteoblast and osteocyte apoptosis, bone formation rate and microarchitecture, crystallinity, vasculature volume, interstitial fluid, and strength. In addition, glucocorticoids suppressed angiogenesis in fetal metatarsals and hypoxia inducible factor-1α transcription and vascular endothelial growth factor production in osteoblasts and osteocytes. These results, together with the evidence that dehydration of bone decreases strength, reveal that endogenous glucocorticoids increase skeletal fragility in old age as a result of cell autonomous effects on osteoblasts and osteocytes leading to interconnected decrements in bone angiogenesis, vasculature volume, and osteocyte-lacunar-canalicular fluid.

KW - 11β-hydroxysteroid dehydrogenase

KW - Aging

KW - Angiogenesis

KW - Apoptosis

KW - Bone histomorphometry

KW - Glucocorticoids

KW - Hydraulic support

KW - Osteoporosis

UR - http://www.scopus.com/inward/record.url?scp=77953271453&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77953271453&partnerID=8YFLogxK

U2 - 10.1111/j.1474-9726.2009.00545.x

DO - 10.1111/j.1474-9726.2009.00545.x

M3 - Article

VL - 9

SP - 147

EP - 161

JO - Aging Cell

JF - Aging Cell

SN - 1474-9718

IS - 2

ER -